BridgeMD
New treatment option for Anterior Cruciate Ligament (ACL)
Official title Preoperative Rehabilitation for Patient With an ACL Injury
ClinicalTrials.gov ID: NCT07411625
What this study is testing
- What it's testing
- Muscle qualities are critical for the recovery after an anterior cruciate ligament (ACL) injury. Before ACL reconstruction (ALCR), resistance training aims to maintain patient strength and volume in order to optimize recovery.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Being over 18 years
- A first episode of an ACL injury
- An ACLR scheduled at least 10 weeks later, with a surgical technique using hamstring, gracilis, or quadriceps/patellar tendon autograft
- A minimum passive range of motion of the knee between 10° of extension deficit, and 80° of flexion
- A medical prescription for prehabilitation
See the full eligibility criteria
- Being over 18 years
- A first episode of an ACL injury
- An ACLR scheduled at least 10 weeks later, with a surgical technique using hamstring, gracilis, or quadriceps/patellar tendon autograft
- A minimum passive range of motion of the knee between 10° of extension deficit, and 80° of flexion
- A medical prescription for prehabilitation
- Possibility to attend prehabilitation program and post-ACLR rehabilitation in one of the 15 clinics
The study team makes the final eligibility decision.
Where it's taking place
- Nantes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nantes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.